Market Place
Sourcing Support
Medigene Receives Milestone Payment from Regeneron Pharma, Inc.
03 Dec 2024 //
GLOBENEWSWIRE
Medigene AG Announces Corporate Strategy Refocus & Realignment
26 Nov 2024 //
GLOBENEWSWIRE
Cash-strapped Medigene lays off 40%, pauses plan to enter clinic
26 Nov 2024 //
FIERCE BIOTECH
Medigene Presents IFN-? Biosensor Data at SITC 2024
12 Nov 2024 //
GLOBENEWSWIRE
Medigene Presents UniTope & TraCR Data at PEGS & SITC 2024
11 Nov 2024 //
GLOBENEWSWIRE
Medigene TCR-Guided Modalities Presentation at Cell 2024
08 Nov 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Investor Conferences
29 Oct 2024 //
GLOBENEWSWIRE
Medigene AG Q3 2024 Financial Results and Business Update
24 Oct 2024 //
GLOBENEWSWIRE
Medigene Presents UniTope And TraCR At ASGCT 2024
17 Oct 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Scientific Conferences
16 Oct 2024 //
GLOBENEWSWIRE
Medigene will Present at ASGCT 2024 and Host R&D Event
02 Oct 2024 //
GLOBENEWSWIRE
Medigene Expands Protection of its KRAS Library Patent Protection
25 Sep 2024 //
GLOBENEWSWIRE
Medigene To Host Virtual R&D Event On Optimal 3S TCRs
16 Sep 2024 //
GLOBENEWSWIRE
Medigene Presents KRAS Library And UniTope & TraCR Tech At ESMO 2024
14 Sep 2024 //
GLOBENEWSWIRE
Medigene Announces FDA Clearance Of IND Application For MDG1015
05 Sep 2024 //
GLOBENEWSWIRE
Medigene Secures Two Additional Patents for Its End-to-End Technology Platform
29 Aug 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
Medigene Implements 2:1 Share Capital Reduction and Consolidation Aug 29
26 Aug 2024 //
GLOBENEWSWIRE
Medigene AG Implements 2:1 Share Capital Reduction And Consolidation
26 Aug 2024 //
GLOBENEWSWIRE
Medigene Reports H1 2024 Financial Results And Corporate Update
14 Aug 2024 //
GLOBENEWSWIRE
Medigene And WuXi Biologics Enter Research Collaboration
08 Aug 2024 //
GLOBENEWSWIRE
Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024
08 Aug 2024 //
GLOBENEWSWIRE
Medigene to Present at ESMO Congress 2024
23 Jul 2024 //
GLOBENEWSWIRE
Medigene Granted Chinese Patent For NY-ESO-1/LAGE 1a T Cell Receptor
03 Jul 2024 //
GLOBENEWSWIRE
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process
27 Jun 2024 //
GLOBENEWSWIRE
Medigene Reports Results of Annual General Meeting
24 Jun 2024 //
GLOBENEWSWIRE
Medigene to Present at Cell and Gene Therapy Summit 2024
21 Jun 2024 //
GLOBENEWSWIRE
Medigene AG Announces Lead Selection For MDG2021, Expanding TCR-T KRAS Library
20 Jun 2024 //
GLOBENEWSWIRE
Medigene Expands its End-to-End Platform by Submitting Three Patents to the EPO
28 May 2024 //
PHARMIWEB
Medigene: Three Patent Filings For Optimization Tech Platform
28 May 2024 //
GLOBENEWSWIRE
Medigene`s BioNTech Research Deal Extended Beyond Initial Term
21 May 2024 //
GLOBENEWSWIRE
Medigene & BioNTech Extend T Cell Receptor Immunotherapy Collaboration
21 May 2024 //
CONTRACT PHARMA
Medigene Presents Data On Optimal TCRs Targeting Mutant KRAS Neoantigen
15 May 2024 //
GLOBENEWSWIRE
Medigene Extends Cash Runway To July 2025 After Successful Raise
14 May 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Conferences
07 May 2024 //
GLOBENEWSWIRE
Medigene Presents Superior TCR-T Cell Data With Costimulatory Switch
02 May 2024 //
GLOBENEWSWIRE
Medigene Expands Patent Portfolio With European NY-ESO-1 TCR Grant
02 May 2024 //
GLOBENEWSWIRE
Medigene AG reports Financial Results and Business Update for Q1 2024
26 Apr 2024 //
GLOBENEWSWIRE
Medigene Presents 6-Day High Stemness TCR-T Production
25 Apr 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Scientific Conferences
17 Apr 2024 //
GLOBENEWSWIRE
Medigene Presents Favorable Safety Profile of TCR-T Cells at AACR
08 Apr 2024 //
GLOBENEWSWIRE
Medigene AG Secures European Patent for its iM-TCR Technology
04 Apr 2024 //
GLOBENEWSWIRE
Medigene AG Reports Full-Year 2023 Financial Results
28 Mar 2024 //
GLOBENEWSWIRE
Medigene to participate in the H.C. Wainwright Virtual Conference
19 Mar 2024 //
GLOBENEWSWIRE
Medigene AG to report full year 2023 financial results on March 28, 2024
18 Mar 2024 //
GLOBENEWSWIRE
Medigene to Present Favorable Safety Profile of TCR-T Cells
06 Mar 2024 //
GLOBENEWSWIRE
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology
04 Mar 2024 //
GLOBENEWSWIRE
Medigene Presents for Development of Differentiated TCR-T Therapies
29 Feb 2024 //
GLOBENEWSWIRE
Medigene to Present at Upcoming Conferences
19 Feb 2024 //
GLOBENEWSWIRE
Medigene Announces Indication Selection for Development of TCR-T Therapy Program
12 Feb 2024 //
GLOBENEWSWIRE
Medigene amends 2023 financial guidance
21 Nov 2023 //
GLOBENEWSWIRE
Medigene AG Announces Prioritization of Pipeline
21 Nov 2023 //
GLOBENEWSWIRE
Medigene Reports Financial Results and Corporate Update for Q3 2023
26 Oct 2023 //
GLOBENEWSWIRE
AGC Biologics Inks TCR-T Cell Services Agreement with Medigene
25 Oct 2023 //
CONTRACT PHARMA
Medigene presents first data of optimal affinity TCR targeting mKRAS G12V
23 Oct 2023 //
GLOBENEWSWIRE
Medigene to present data for pipeline TCR-T therapies at the ESMO Congress 2023
16 Oct 2023 //
GLOBENEWSWIRE
Medigene Secures European Patent for its PD1-41BB Costimulatory Switch Protein
27 Sep 2023 //
GLOBENEWSWIRE
Medigene Announces Selection for MDG2011 Representing the First TCR-T Therapy
18 Sep 2023 //
GLOBENEWSWIRE
Medigene AG to present at the Baader Investment Conference 2023
11 Sep 2023 //
GLOBENEWSWIRE
Medigene AG to present at the H.C. Wainwright 25th Annual Global Conference
05 Sep 2023 //
GLOBENEWSWIRE
